Literature DB >> 11207537

Identification of the intimin-binding domain of Tir of enteropathogenic Escherichia coli.

M de Grado1, A Abe, A Gauthier, O Steele-Mortimer, R DeVinney, B B Finlay.   

Abstract

Enteropathogenic Escherichia coli (EPEC) attaches intimately to mammalian cells via a bacterial outer membrane adhesion molecule, intimin, and its receptor in the host cell membrane, Tir. Tir is a bacterial protein translocated into the host cell membrane and tyrosine phosphorylated after insertion. Tir-intimin binding induces organized actin polymerization beneath the adherent bacteria, resulting in the formation of pedestal-like structures. A series of Tir deletion derivatives were constructed to analyse which Tir domains are involved in intimin binding. We have localized the intimin-binding domain (IBD) of Tir using a yeast two-hybrid system and a gel-overlay approach to a region of 109 amino acids that is predicted to be exposed on the surface of the plasma membrane. A truncated Tir protein lacking this domain was translocated to the host cell membrane and tyrosine phosphorylated, but failed to bind intimin or to induce either actin polymerization or Tir accumulation beneath the bacteria. These results indicate that only a small region of Tir is needed to bind intimin and support the predicted topology for Tir, with both N- and C-terminal regions in the mammalian cell cytosol. They also confirm that Tir-intimin interactions are needed for cytoskeletal organization. We have also identified N-terminal regions involved in Tir stability and Tir secretion to the media.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11207537     DOI: 10.1046/j.1462-5822.1999.00001.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  26 in total

1.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Enteropathogenic Escherichia coli (EPEC) Tir receptor molecule does not undergo full modification when introduced into host cells by EPEC-independent mechanisms.

Authors:  B Kenny; J Warawa
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization.

Authors:  Annick Gauthier; Jose Luis Puente; B Brett Finlay
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

4.  Atypical Enteropathogenic Escherichia coli: from Kittens to Humans and Beyond!

Authors:  Shantanu Bhatt
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

5.  Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection.

Authors:  Laura Q Leverton; James B Kaper
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

8.  Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization.

Authors:  Theresa D Ho; Brigid M Davis; Jennifer M Ritchie; Matthew K Waldor
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

9.  Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs.

Authors:  Dapeng Yan; Xingyu Wang; Lijun Luo; Xuetao Cao; Baoxue Ge
Journal:  Nat Immunol       Date:  2012-09-23       Impact factor: 25.606

10.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.